Attributable mortality of ICU acquired bloodstream infections: a propensity-score matched analysis.
Bacteremia
Critical care
Mortality
Propensity score
Journal
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297
Informations de publication
Date de publication:
Aug 2021
Aug 2021
Historique:
received:
16
07
2020
accepted:
01
03
2021
pubmed:
12
3
2021
medline:
31
8
2021
entrez:
11
3
2021
Statut:
ppublish
Résumé
The mortality attributable to ICU-acquired bloodstream infection (BSI) differs between studies due to statistical methods used for cohort matching. Propensity-score matching has never been used to avoid eventual bias when studying BSI attributable mortality in the ICU. We conducted an observational prospective study over a 4-year period, on patients admitted for at least 48 h in 2 intensive care units. Based on risk factors for death in the ICU and for BSI, each patient with BSI was matched with 3 patients without BSI using propensity-score matching. We performed a competitive risk analysis to study BSI mortality attributable fraction. Of 2464 included patients, 71 (2.9%) had a BSI. Propensity-score matching was highly effective and group characteristics were fully balanced. Crude mortality was 36.6% in patients with BSI and 21.6% in propensity-score matched patients (p=0.018). Attributable mortality of BSI was 2.3% [1.2-4.0] and number needed to harm was 6.7. With Fine and Gray model, a higher risk for death was observed in patients with BSI than in propensity-score matched patients (sub distribution Hazard Ratio (sdHR) = 2.11; 95% CI [1.32-3.37] p = 0.002). Patients with BSI had a higher risk for death and BSI attributable mortality fraction was 2.3%.
Identifiants
pubmed: 33694037
doi: 10.1007/s10096-021-04215-4
pii: 10.1007/s10096-021-04215-4
pmc: PMC7945601
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1673-1680Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Medicine (Baltimore). 2014 Oct;93(17):298-309
pubmed: 25398065
Crit Care. 2011;15(2):R100
pubmed: 21418635
J Perinatol. 2002 Mar;22(2):137-43
pubmed: 11896519
Am J Infect Control. 1988 Jun;16(3):128-40
pubmed: 2841893
J Hosp Infect. 2008 May;69(1):56-61
pubmed: 18353495
Am J Epidemiol. 2009 Jul 15;170(2):244-56
pubmed: 19494242
JAMA. 2009 Dec 2;302(21):2323-9
pubmed: 19952319
Antimicrob Agents Chemother. 2005 Feb;49(2):760-6
pubmed: 15673761
J Antimicrob Chemother. 2015 Jan;70(1):273-8
pubmed: 25190722
J Infect. 2017 Feb;74(2):131-141
pubmed: 27838521
Clin Infect Dis. 2006 Apr 15;42(8):1118-26
pubmed: 16575729
Eur J Clin Microbiol Infect Dis. 2020 May;39(5):889-895
pubmed: 31898797
Am J Respir Crit Care Med. 1999 Sep;160(3):976-81
pubmed: 10471627
Chest. 2003 Apr;123(4):1208-13
pubmed: 12684313
Stat Med. 2007 May 20;26(11):2389-430
pubmed: 17031868
Am J Respir Crit Care Med. 2001 Jun;163(7):1584-90
pubmed: 11401878
Infect Control Hosp Epidemiol. 2007 Jan;28(1):31-5
pubmed: 17315338
Curr Opin Crit Care. 2011 Oct;17(5):464-71
pubmed: 21844801
Intensive Care Med. 2012 Dec;38(12):1930-45
pubmed: 23011531